KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bausch Health Companies (BHC) Total Non-Current Liabilities (2016 - 2025)

Bausch Health Companies' Total Non-Current Liabilities history spans 17 years, with the latest figure at $26.5 billion for Q3 2025.

  • For Q3 2025, Total Non-Current Liabilities rose 2.19% year-over-year to $26.5 billion; the TTM value through Sep 2025 reached $26.5 billion, up 2.19%, while the annual FY2024 figure was $27.1 billion, 1.62% up from the prior year.
  • Total Non-Current Liabilities for Q3 2025 was $26.5 billion at Bausch Health Companies, up from $26.2 billion in the prior quarter.
  • Across five years, Total Non-Current Liabilities topped out at $29.7 billion in Q2 2021 and bottomed at $24.5 billion in Q2 2023.
  • The 5-year median for Total Non-Current Liabilities is $26.5 billion (2025), against an average of $26.8 billion.
  • The largest annual shift saw Total Non-Current Liabilities skyrocketed 1984.34% in 2021 before it fell 14.41% in 2023.
  • A 5-year view of Total Non-Current Liabilities shows it stood at $28.6 billion in 2021, then fell by 13.64% to $24.7 billion in 2022, then grew by 7.98% to $26.7 billion in 2023, then rose by 1.62% to $27.1 billion in 2024, then fell by 2.0% to $26.5 billion in 2025.
  • Per Business Quant, the three most recent readings for BHC's Total Non-Current Liabilities are $26.5 billion (Q3 2025), $26.2 billion (Q2 2025), and $25.9 billion (Q1 2025).